Guilin Layn Natural Ingredients Corp.
莱茵生物
002166
Shenzhen Stock Exchange
Company Overview
Guilin Layn Natural Ingredients Corp. is a manufacturing company listed on the Shenzhen Stock Exchange since 2007. The company specializes in the production and operation of natural health products, focusing on the research and extraction of plant functional ingredients. It has developed extraction technology for over 300 standardized plant extract products, including extracts from siraitia grosvenorii, stevia rebaudiana, and tea, among others. The company's operations span the agricultural sector upstream and various downstream applications, including food, beverages, health products, beauty and skincare, medicine, and animal feed. As the first listed company in China's plant extraction industry, Guilin Layn has established a leading position globally, supported by a comprehensive industry chain, technological innovation, and significant global influence. The company operates three major production bases, four marketing centers, and five research and development centers, featuring advanced digital extraction factories and synthetic biology workshops. Its flagship product, siraitia grosvenorii extract, showcases the company's ability to control the supply chain from cultivation to final products. Guilin Layn is also recognized for its extensive patent portfolio and international collaborations, positioning itself as a trusted provider of natural health products.
AI-generated from company disclosures and CNInfo data.
Company Profile
As the first listed company in the domestic plant extraction industry, the company has established its leading position in the global plant extraction field with authoritative certifications such as national level green factory and national level specialized and innovative "little giant" enterprise, relying on three core advantages of full industry chain layout, technological innovation, and global influence. The company has established a global strategic layout of three major production bases, four marketing centers, and five research and development centers, and has industry-leading digital intelligent comprehensive extraction factories and synthetic biology workshops. The company's main single product production capacity and sales volume of natural sweeteners remain among the top three in the world. The tea extract category covers all components and has a leading market share, making it one of the few manufacturers in the United States to achieve large-scale supply of industrial cannabis extract. The company controls the supply of core raw materials through the "company+base+farmer" mode, and the flagship product "Siraitia grosvenorii extract" has formed the full chain control ability from seedling cultivation to terminal products. Supported by the postdoctoral research workstation, Guangxi Natural Sweetener Technology Innovation Center and other research and development platforms, the company has obtained 170 invention and utility model patents in total, overcome industrial problems such as the total synthesis technology of siraitia grosvenorii glycosides and the RM series mass production technology of stevioside, and constantly promote the industry to upgrade to high added value; The company has achieved commercialization of L-beta-galactan in the field of synthetic biology, setting a benchmark for industry technological innovation and strengthening its own technological barriers in the industry. As the chairman unit of the China Stevia Association and the executive director unit of the China Chamber of Commerce for Import and Export of Medicines and Health Products, the company has built international recognition through the "LayInSide" brand strategy, expanded its marketing layout to the global markets of Europe, America, and Asia, and established deep cooperative relationships with globally renowned enterprises, forming a high-end customer matrix. Looking ahead to the future, the company will continue to adhere to the business philosophy of "green technology, healthy future", rely on its strong advantages in integrated production, sales, and research, adhere to the development strategy of large products, and strive to become the most trusted natural health product service provider in the world.
Key Financials
As of 2026-06-20T00:00:00.000+00:00Announcements
Notes & Comments
Sign in to leave a comment or private note.
No notes or comments yet.